Low Dose Vitamin A Derivative Not Effective In Cancer
Prevention

Taking a vitamin A derivative called isotretinoin did not reduce the risk of second primary tumors or improve survival in patients with stage I or II head and neck squamous cell cancers (HNSCC), as per a research studyin the April 5 issue of the Journal of the National Cancer Institute. In addition, current smokers had an increased risk of second primary cancers and death........

Read The Full Article:
http://www.drilltools.org/286

Add to del.icio.us

Digg this

Post to Furl

Add to reddit

Add to myYahoo!